Left ventricular hypertrophy with qrs widening and repolarization abnormality

Last week’s 5-minute EKG discussion was lead by our APD, Dr. Scott Heinrich.

You get handed this EKG from a patient in triage with chest pain. Should you activate the cath lab?

Left ventricular hypertrophy with qrs widening and repolarization abnormality

The answer: No

This EKG is showing left ventricular hypertrophy (LVH) with repolarization abnormality, also known as LVH with strain. This can be easily confused for ischemia, so how do we differentiate between the two?

First and foremost, you must meet criteria for left ventricular hypertrophy. While the gold standard for diagnosing LVH is through echo, there are several different EKG criteria we can use to diagnose LVH, including:

  • S wave depth in V1 + tallest R wave height in V5 or V6 > 35 mm (Sokolov Lyon Criteria)
  • R wave in aVL and S wave in V3 > 20mm (female) or >28mm (male) (Cornell Criteria)
  • R in aVL > 11mm
  • And several other criteria, although these are the most common

In LVH, the myocardium becomes thickened, which causes the electricity to move more slowly through the heart. This slowed conduction causes widening of the QRS and repolarization abnormalities. This will appear on EKG as increased R wave peak time of >50ms in leads V5 or V6 and ST depressions with T wave inversions in lateral (left-sided) leads. It is important to note that in LVH with strain, T wave inversions are often asymmetric, in contrast to the symmetric t wave inversions often seen in ischemia.

Left ventricular hypertrophy with qrs widening and repolarization abnormality

Ex: Deep, symmetric inverted t waves in Wellen’s (type B)

In summary, in LVH with strain you will see:

  • Lateral leads (I, aVL, V5 – V6) with increased R wave amplitude, time to peak R wave at least 50ms, and ST depressions with asymmetric inverted t waves
  • Inferior and anterior/septal leads with deep S waves and ST elevations in V1-V3 (discordant to deep S)

Lastly, here are some tips from EKG guru Amal Mattu that may help to differentiate between LVH with strain and ischemia:

  • If voltage criteria for LVH is not met, assume ischemia
  • Asymmetric T wave inversions favor LVH with strain (although this is NOT always the case, you can have asymmetric TWI in ischemia)
  • Horizontal ST elevations and depressions should be concerning for ischemia

Resources:

  1. Life In the Fast Lane – LVH
  2. Amal Mattu ECG weekly – LVH with strain

"LVH" redirects here. For the Las Vegas hotel formerly known as "LVH", see Westgate Las Vegas.

Left ventricular hypertrophy
Left ventricular hypertrophy with qrs widening and repolarization abnormality
A heart with left ventricular hypertrophy in short-axis view
SpecialtyCardiology
ComplicationsHypertrophic cardiomyopathy, Heart failure[1]
Diagnostic methodEchocardiography, cardiovascular MRI[1]
Differential diagnosisAthletic heart syndrome

Left ventricular hypertrophy (LVH) is thickening of the heart muscle of the left ventricle of the heart, that is, left-sided ventricular hypertrophy and resulting increased left ventricular mass.

Causes[edit]

While ventricular hypertrophy occurs naturally as a reaction to aerobic exercise and strength training, it is most frequently referred to as a pathological reaction to cardiovascular disease, or high blood pressure.[2] It is one aspect of ventricular remodeling.

While LVH itself is not a disease, it is usually a marker for disease involving the heart.[3] Disease processes that can cause LVH include any disease that increases the afterload that the heart has to contract against, and some primary diseases of the muscle of the heart.[citation needed] Causes of increased afterload that can cause LVH include aortic stenosis, aortic insufficiency and hypertension. Primary disease of the muscle of the heart that cause LVH are known as hypertrophic cardiomyopathies, which can lead into heart failure.[citation needed]

Long-standing mitral insufficiency also leads to LVH as a compensatory mechanism.[citation needed]

Associated genes include OGN, osteoglycin.[4]

Diagnosis[edit]

The commonly used method to diagnose LVH is echocardiography, with which the thickness of the muscle of the heart can be measured. The electrocardiogram (ECG) often shows signs of increased voltage from the heart in individuals with LVH, so this is often used as a screening test to determine who should undergo further testing.[citation needed]

Echocardiography[edit]

Left ventricular hypertrophy grading
by posterior wall thickness[5]
Mild 12 to 13 mm
Moderate >13 to 17 mm
Severe >17 mm

Two dimensional echocardiography can produce images of the left ventricle. The thickness of the left ventricle as visualized on echocardiography correlates with its actual mass. Left ventricular mass can be further estimated based on geometric assumptions of ventricular shape using the measured wall thickness and internal diameter.[6] Average thickness of the left ventricle, with numbers given as 95% prediction interval for the short axis images at the mid-cavity level are:[7]

  • Women: 4 – 8 mm
  • Men: 5 – 9 mm

CT & MRI[edit]

CT and MRI-based measurement can be used to measure the left ventricle in three dimensions and calculate left ventricular mass directly. MRI based measurement is considered the “gold standard” for left ventricular mass,[8] though is usually not readily available for common practice. In older individuals, age related remodeling of the left ventricle's geometry can lead to a discordancy between CT and echocardiographic based measurements of left ventricular mass.[9]

ECG criteria[edit]

Left ventricular hypertrophy with qrs widening and repolarization abnormality

Left ventricular hypertrophy with secondary repolarization abnormalities as seen on ECG

Left ventricular hypertrophy with qrs widening and repolarization abnormality

Histopathology of (a) normal myocardium and (b) myocardial hypertrophy. Scale bar indicates 50 μm.

Left ventricular hypertrophy with qrs widening and repolarization abnormality

Gross pathology of left ventricular hypertrophy. Left ventricle is at right in image, serially sectioned from apex to near base.

There are several sets of criteria used to diagnose LVH via electrocardiography.[10] None of them are perfect, though by using multiple criteria sets, the sensitivity and specificity are increased.

The Sokolow-Lyon index:[11][12]

  • S in V1 + R in V5 or V6 (whichever is larger) ≥ 35 mm (≥ 7 large squares)
  • R in aVL ≥ 11 mm

The Cornell voltage criteria[13] for the ECG diagnosis of LVH involve measurement of the sum of the R wave in lead aVL and the S wave in lead V3. The Cornell criteria for LVH are:

  • S in V3 + R in aVL > 28 mm (men)
  • S in V3 + R in aVL > 20 mm (women)

The Romhilt-Estes point score system ("diagnostic" >5 points; "probable" 4 points):

ECG Criteria Points
Voltage Criteria (any of):
  1. R or S in limb leads ≥20 mm
  2. S in V1 or V2 ≥30 mm
  3. R in V5 or V6 ≥30 mm
3
ST-T Abnormalities:
  • ST-T vector opposite to QRS without digitalis
  • ST-T vector opposite to QRS with digitalis

3
1

Negative terminal P mode in V1 1 mm in depth and 0.04 sec in duration (indicates left atrial enlargement) 3
Left axis deviation (QRS of −30° or more) 2
QRS duration ≥0.09 sec 1
Delayed intrinsicoid deflection in V5 or V6 (>0.05 sec) 1

Other voltage-based criteria for LVH include:

  • Lead I: R wave > 14 mm
  • Lead aVR: S wave > 15 mm
  • Lead aVL: R wave > 12 mm
  • Lead aVF: R wave > 21 mm
  • Lead V5: R wave > 26 mm
  • Lead V6: R wave > 20 mm

Treatment[edit]

Treatment is typically focused on resolving the cause of the LVH with the enlargement not permanent in all cases. In some cases the growth can regress with the reduction of blood pressure.[14]

LVH may be a factor in determining treatment or diagnosis for other conditions, for example, LVH is used in the staging and risk stratification of Non-ischemic cardiomyopathies such as Fabry's Disease.[15] Patients with LVH may have to participate in more complicated and precise diagnostic procedures, such as Echocardiography or Cardiac MRI.[16][17]

See also[edit]

  • Cardiomegaly
  • Primary hyperparathyroidism
  • Ventricular hypertrophy

References[edit]

  1. ^ a b Maron, Barry J; Maron, Martin S (2013-01-19). "Hypertrophic cardiomyopathy". Lancet. Elsevier BV. 381 (9862): 242–255. doi:10.1016/s0140-6736(12)60397-3. ISSN 0140-6736. PMID 22874472. S2CID 38333896.
  2. ^ "Ask the doctor: Left Ventricular Hypertrophy". Retrieved 2007-12-07.
  3. ^ Meijs MF, Bots ML, Vonken EJ, et al. (2007). "Rationale and design of the SMART Heart study: A prediction model for left ventricular hypertrophy in hypertension". Neth Heart J. 15 (9): 295–8. doi:10.1007/BF03086003. PMC 1995099. PMID 18030317.
  4. ^ Petretto E, Sarwar R, Grieve I, Lu H, Kumaran MK, Muckett PJ, Mangion J, Schroen B, Benson M, Punjabi PP, Prasad SK, Pennell DJ, Kiesewetter C, Tasheva ES, Corpuz LM, Webb MD, Conrad GW, Kurtz TW, Kren V, Fischer J, Hubner N, Pinto YM, Pravenec M, Aitman TJ, Cook SA (May 2008). "Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass". Nat. Genet. 40 (5): 546–52. doi:10.1038/ng.134. PMC 2742198. PMID 18443592.
  5. ^ Goland, Sorel; Czer, Lawrence S.C.; Kass, Robert M.; Siegel, Robert J.; Mirocha, James; De Robertis, Michele A.; Lee, Jason; Raissi, Sharo; Cheng, Wen; Fontana, Gregory; Trento, Alfredo (2008). "Use of Cardiac Allografts With Mild and Moderate Left Ventricular Hypertrophy Can Be Safely Used in Heart Transplantation to Expand the Donor Pool". Journal of the American College of Cardiology. 51 (12): 1214–1220. doi:10.1016/j.jacc.2007.11.052. ISSN 0735-1097. PMID 18355661.
  6. ^ Lang, Roberto M.; Badano, Luigi P.; Mor-Avi, Victor; Afilalo, Jonathan; Armstrong, Anderson; Ernande, Laura; Flachskampf, Frank A.; Foster, Elyse; Goldstein, Steven A.; Kuznetsova, Tatiana; Lancellotti, Patrizio; Muraru, Denisa; Picard, Michael H.; Rietzschel, Ernst R.; Rudski, Lawrence (January 2015). "Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging". Journal of the American Society of Echocardiography. 28 (1): 1–39.e14. doi:10.1016/j.echo.2014.10.003. hdl:1854/LU-5953422. ISSN 1097-6795. PMID 25559473.
  7. ^ Kawel, Nadine; Turkbey, Evrim B.; Carr, J. Jeffrey; Eng, John; Gomes, Antoinette S.; Hundley, W. Gregory; Johnson, Craig; Masri, Sofia C.; Prince, Martin R.; van der Geest, Rob J.; Lima, João A.C.; Bluemke, David A. (2012). "Normal Left Ventricular Myocardial Thickness for Middle-Aged and Older Subjects With Steady-State Free Precession Cardiac Magnetic Resonance". Circulation: Cardiovascular Imaging. 5 (4): 500–508. doi:10.1161/CIRCIMAGING.112.973560. ISSN 1941-9651. PMC 3412148. PMID 22705587.
  8. ^ Myerson, Saul G.; Bellenger, Nicholas G.; Pennell, Dudley J. (2002-03-01). "Assessment of Left Ventricular Mass by Cardiovascular Magnetic Resonance". Hypertension. 39 (3): 750–755. doi:10.1161/hy0302.104674. PMID 11897757. S2CID 16598370.
  9. ^ Stokar, Joshua; Leibowitz, David; Durst, Ronen; Shaham, Dorith; Zwas, Donna R. (2019-10-24). "Echocardiography overestimates LV mass in the elderly as compared to cardiac CT". PLOS ONE. 14 (10): e0224104. Bibcode:2019PLoSO..1424104S. doi:10.1371/journal.pone.0224104. ISSN 1932-6203. PMC 6812823. PMID 31648248.
  10. ^ "Lesson VIII - Ventricular Hypertrophy". Retrieved 2009-01-07.
  11. ^ Sokolow M, Lyon TP (1949). "The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads". Am Heart J. 37 (2): 161–186. doi:10.1016/0002-8703(49)90562-1. PMID 18107386.
  12. ^ Okin, Peter M.; Roman, Mary J.; Devereux, Richard B.; Pickering, Thomas G.; Borer, Jeffrey S.; Kligfield, Paul (1998). "Time-Voltage QRS Area of the 12-Lead Electrocardiogram : Detection of Left Ventricular Hypertrophy". Hypertension. 31 (4): 937–942. CiteSeerX 10.1.1.503.8356. doi:10.1161/01.HYP.31.4.937. PMID 9535418. S2CID 2662286. Retrieved 2007-12-07.
  13. ^ Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P (1987). "Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings". Circulation. 75 (3): 565–72. doi:10.1161/01.CIR.75.3.565. PMID 2949887.
  14. ^ Gradman AH, Alfayoumi F (2006). "From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease". Prog Cardiovasc Dis. 48 (5): 326–41. doi:10.1016/j.pcad.2006.02.001. PMID 16627048.
  15. ^ Tower-Rader, Albree; Jaber, Wael A. (1 November 2019). "Multimodality Imaging Assessment of Fabry Disease". Circulation: Cardiovascular Imaging. 12 (11): e009013. doi:10.1161/CIRCIMAGING.119.009013.
  16. ^ American Society of Nuclear Cardiology, "Five Things Physicians and Patients Should Question" (PDF), Choosing Wisely: an initiative of the ABIM Foundation, American Society of Nuclear Cardiology, archived from the original (PDF) on April 16, 2012, retrieved August 17, 2012
  17. ^ Anderson, J. L.; Adams, C. D.; Antman, E. M.; Bridges, C. R.; Califf, R. M.; Casey, D. E.; Chavey, W. E.; Fesmire, F. M.; Hochman, J. S.; Levin, T. N.; Lincoff, A. M.; Peterson, E. D.; Theroux, P.; Wenger, N. K.; Wright, R. S. (2007). "ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction): Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine". Circulation. 116 (7): 803–877. doi:10.1161/CIRCULATIONAHA.107.185752.

What does left ventricular hypertrophy with repolarization abnormality mean?

Left ventricular hypertrophy is a thickening of the wall of the heart's main pumping chamber. This thickening may result in elevation of pressure within the heart and sometimes poor pumping action. The most common cause is high blood pressure.

What is left ventricular hypertrophy with QRS widening?

When the myocardium as abnormally thickened, electrical activity takes longer to traverse throughout the whole heart, thus the duration of the QRS complex may be widened. This is referred to as "LVH with QRS widening".

Is left ventricular hypertrophy life threatening?

What is the prognosis (outlook) for people with left ventricular hypertrophy? Left untreated, LVH (and related underlying heart conditions) increases your risk of serious heart disease or even death. Treatment to slow or stop the progression of left ventricular hypertrophy lowers the risk of severe heart damage.

What is the life expectancy of someone with left ventricular hypertrophy?

The majority of patients with hypertrophic cardiomyopathy have no symptoms and most have a near-normal life expectancy.